Syndromic Multiplex Diagnostic Market Research, Business With Abbott, Accelerate Diagnostics, Akonni Biosystems, Inc., Alveo Technologies, Applied BioCode, Inc., Binx Health, Inc., BD, Biocartis, And More

This Syndromic Multiplex Diagnostic market research report explores the key parameters for Syndromic Multiplex industry namely market analysis, market definition, market segmentation, key developments in the market, competitive analysis, and research methodology. This report gives estimations of Compound Annual Growth Rate (CAGR) in % value for the forecasted period that will assist client to take decision based on futuristic chart. The report defines CAGR value fluctuations during the forecast period of 2019-2026 for the market. For obtaining in depth market report, request an analyst call or drop down an enquiry at any time.

Syndromic Multiplex Diagnostic Market is set to witness a stable CAGR in the forecast period of 2019-2026. The report contains the data of the base year 2018 and historic year 2017.

Get Free Sample Analysis of This Market Information:

Increasing demand for accurate results is major factor for the growth of this market.

To provide market definition, Syndromic Multiplex Diagnostic report neatly researches market driving factors and market restraints. It aids in estimating the demand of particular product in the market with respect to several aspects. In the same way, market segmentation is another major parameter that categories the market depending upon application, vertical, deployment model, end-user, and geography etc. To perform competitive analysis, a range of strategies of the major players in the market have been believed that include new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others which lead to an ascend of their footprints in the market. The Syndromic Multiplex Diagnostic report provides market shares at global level mainly for Europe, North America, Asia Pacific and South America. Few of the major competitors currently working in the syndromic multiplex diagnostic market are

  • Abbott
  • Accelerate Diagnostics, Inc.
  • Akonni Biosystems, Inc.
  • Alveo Technologies
  • Applied BioCode, Inc.
  • Binx Health, Inc.
  • BD
  • Biocartis,
  • BioFire Diagnostics
  • bioMérieux SA
  • Bio-Rad Laboratories, Inc
  • Bosch Healthcare Solutions GmbH
  • Cepheid

Other Players are Diagenode Diagnostics, GenePOC Inc,  GenMark Diagnostics, Inc., Hologic, Inc.,   Inflammatix, Inc., Janssen Global Services, LLC, Mesa Biotech. Syndromic multiplex diagnostic is the test which is used to identify respiratory infection, infective gastroenteritis, and other viral, bacterial or fungal infections. They help the clinicians to identify the symptoms and signs of the disease. It helps the healthcare provider to provide correct patient care. It provides result more accurately so that treatment can be done immediately and faster.

Market Drivers

  • Increasing demand for accurate and fast results is driving the growth of this market
  • Affordable price of this test is another factor driving the market

 Get TOC For Full Analysis Of Report:

 Market Restraints

  • Lack of acceptance by doctors is restraining the market growth
  • The inability to detect asymptomatic cases is another major factor restraining the market

Segmentation: Global Syndromic Multiplex Diagnostic Market

By Infectious Diseases

  • HIV – Human Immunodeficiency Virus (AIDS)
    • Virology
  • Classification
  • Structure and Genome
  • Tropism
  • Replication Cycle
  • Genetic Variability
  • Diagnosis
  • Testing
  • Antibody Tests
  • Point of Care Tests (POCT)
  • Antigen Tests
  • Nucleic Acid-based Tests (NAT)
  • Other Tests Used in HIV Treatment
  • HBV – Hepatitis B
    • Virology
  • Genome
  • Pathogenesis
  • Hepatitis B Virus Replication
  • Serotypes and Genotypes
  • Mechanisms
  • Diagnosis
  • HCV – Hepatitis C
    • Taxonomy
  • Structure
  • Genome
  • Molecular Biology
  • Replication
  • Genotypes
  • Clinical Importance
  • HPV – Human papillomavirus
  • Virology
    • E6/E7 Proteins
    • Role in Cancer
    • E2 Research
    • Latency Period
    • Clearance
  • Diagnosis
    • Cervical Testing
    • Oral Testing
    • Testing Men
    • Other Testing
  •  Influenza
    • Virology
  • Influenza A virus
  • Influenza B virus
  • Influenza C virus
  • Structure, Properties, and Subtype Nomenclature
  • Replication
    • Testing
  •  CTGC – Chlamydia/Gonorrhea
    • Gonorrhea
      • Diagnosis
      • Screening
    • Chlamydia
      • Diagnosis
      • Screening
    • Testing
      • Nucleic-acid Amplification Tests (NAATs).
      • Performance of NAAT Tests
    •  Tuberculosis
      • Mycobacteria
      • Diagnosis
        • Active Tuberculosis
        • Latent Tuberculosis
      • Epidemiology
      • Molecular Diagnostic Tests
    •  MRSA – Methicillin-resistant Staphylococcus aureus
      • Diagnosis
      • FDA Approved Molecular Tests
    •  VRE – Vancomycin-resistant Enterococcus
      • FDA Approved MDx Tests for VRE
  • By Syndrome
  • Bloodstream
  • Respiratory
  • Gastrointestinal
  • Central Nervous System
  • By Geography
  • North America
    • US.
    • Canada
    • Mexico
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Turkey
  • Belgium
  • Netherlands
  • Switzerland
  • Rest of Europe
  • Asia-Pacific
  • Japan
  • China
  • South Korea
  • India
  • Australia
  • Singapore
  • Thailand
  • Malaysia
  • Indonesia
  • Philippines
  • Rest of Asia Pacific
  • Middle East & Africa
  • South Africa
  • Egypt
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Rest of Middle East & Africa

Key Developments in the Market:

  • In November 2018, bioMérieux announced that they have got approval from Food and Drug Administration (FDA) for their BIOFIRE FILMARRAY Pneumonia Panel and the CE-Mark of the BIOFIRE FILMARRAY Pneumonia Panel plus which is specially designed for the diagnosis of respiratory infections. It will help the clinicians to identify the microorganisms that cause similar problems that too quickly and reliably.
  • In October 2018, QIAGEN N.V. announced the launch of their next-generation QIAstat-Dx panel which is used for identify gastrointestinal (GI) syndromes. This is designed in such a way so that hospitals, laboratories and clinics can be easy to use and diagnose the complex syndromes easily. The main aim is to meet the growing demand for syndromic testing.

Competitive Analysis:

Global syndromic multiplex diagnostic market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of syndromic multiplex diagnostic market for global, Europe, North America, Asia Pacific, South America and Middle East & Africa.

 Reasons to Purchase this Report

  • Current and future of global syndromic multiplex diagnostic market outlook in the developed and emerging markets
  • The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period
  • Regions/Countries that are expected to witness the fastest growth rates during the forecast period
  • The latest developments, market shares, and strategies that are employed by the major market players

Want Full Report? Enquire Here For Custom Requirements:


About Us

Data Bridge Market Research is a versatile market research and consulting firm with over 500 analysts working in different industries. We have catered more than 40% of the fortune 500 companies globally and have a network of more than 5000+ clientele around the globe. Our coverage of industries include Medical Devices, Pharmaceuticals, Biotechnology, Semiconductors, Machinery, Information and Communication Technology, Automobiles and Automotive, Chemical and Material, Packaging, Food and Beverages, Cosmetics, Specialty Chemicals, Fast Moving Consumer Goods, Robotics, among many others.

Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. Get Customization and Discount on Report by emailing . We are content with our glorious 99.9 % client satisfying rate.

Contact Us

Data Bridge Market Research

US: +1 888 387 2818

UK: +44 208 089 1725

Hong Kong: +852 8192 7475


Related Articles